- NeurAxis Announces New Medical Policy Coverage in North Dakota
- NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
- NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024
- NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry
- NeurAxis Announces Highmark BCBS Policy Coverage
- NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage
- NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- NeurAxis Appoints Timothy Henrichs as Chief Financial Officer
- NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer
- NeurAxis Reports Third Quarter 2023 Financial Results
More ▼
Key statistics
On Thursday, Neuraxis Inc (NRXS:ASQ) closed at 3.30, 83.33% above the 52 week low of 1.80 set on Oct 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.24 |
---|---|
High | 3.30 |
Low | 3.15 |
Bid | 2.86 |
Offer | 5.23 |
Previous close | 3.30 |
Average volume | 8.31k |
---|---|
Shares outstanding | 6.59m |
Free float | 4.08m |
P/E (TTM) | -- |
Market cap | 21.76m USD |
EPS (TTM) | -3.78 USD |
Data delayed at least 15 minutes, as of May 02 2024 23:30 BST.
More ▼